Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

A new MBTPS2 gene variant disrupts fat metabolism and collagen production, causing Osteogenesis imperfecta.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Disrupting the Tsc2 gene in certain cells leads to thicker skin, larger hair, and changes in hair growth signaling, which can be partly reversed with specific treatment.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Botulinum toxin is used to treat many medical conditions beyond cosmetic purposes.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

MK-5108 is safe and shows potential against tumors, especially alone.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Tanshinone compounds can help prevent hair loss caused by testosterone.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Progesterone reduces anxiety without needing progesterone receptors.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Botulinum toxin injections do not help with male pattern baldness.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.